1. Home
  2. CLGN vs CREX Comparison

CLGN vs CREX Comparison

Compare CLGN & CREX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLGN
  • CREX
  • Stock Information
  • Founded
  • CLGN 2004
  • CREX N/A
  • Country
  • CLGN Israel
  • CREX United States
  • Employees
  • CLGN N/A
  • CREX N/A
  • Industry
  • CLGN Industrial Specialties
  • CREX EDP Services
  • Sector
  • CLGN Health Care
  • CREX Technology
  • Exchange
  • CLGN Nasdaq
  • CREX Nasdaq
  • Market Cap
  • CLGN 33.8M
  • CREX 35.2M
  • IPO Year
  • CLGN N/A
  • CREX N/A
  • Fundamental
  • Price
  • CLGN $2.66
  • CREX $2.31
  • Analyst Decision
  • CLGN Strong Buy
  • CREX Strong Buy
  • Analyst Count
  • CLGN 2
  • CREX 1
  • Target Price
  • CLGN $11.50
  • CREX $6.00
  • AVG Volume (30 Days)
  • CLGN 30.5K
  • CREX 46.8K
  • Earning Date
  • CLGN 08-20-2025
  • CREX 11-12-2025
  • Dividend Yield
  • CLGN N/A
  • CREX N/A
  • EPS Growth
  • CLGN N/A
  • CREX N/A
  • EPS
  • CLGN N/A
  • CREX N/A
  • Revenue
  • CLGN $2,402,000.00
  • CREX $48,218,000.00
  • Revenue This Year
  • CLGN $1,617.28
  • CREX $4.96
  • Revenue Next Year
  • CLGN $83.54
  • CREX $21.73
  • P/E Ratio
  • CLGN N/A
  • CREX N/A
  • Revenue Growth
  • CLGN 248.62
  • CREX N/A
  • 52 Week Low
  • CLGN $1.31
  • CREX $1.28
  • 52 Week High
  • CLGN $5.00
  • CREX $4.85
  • Technical
  • Relative Strength Index (RSI)
  • CLGN 52.88
  • CREX 42.57
  • Support Level
  • CLGN $2.38
  • CREX $2.21
  • Resistance Level
  • CLGN $2.77
  • CREX $2.38
  • Average True Range (ATR)
  • CLGN 0.18
  • CREX 0.15
  • MACD
  • CLGN -0.02
  • CREX 0.00
  • Stochastic Oscillator
  • CLGN 47.46
  • CREX 19.61

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.

About CREX Creative Realities Inc.

Creative Realities Inc, along with its subsidiaries, is engaged in providing digital marketing technology & solutions to world-wide retail companies, luxury and other individual retail brands, advertising networks, outdoor clients, enterprises, and other organizations. The Company operates in one reportable segment, marketing technology solutions. The company provides solutions related to digital merchandising systems, omnichannel customer engagement systems, interactive digital shopping assistants, advisors and kiosks, and high-end audio-visual networks along with marketing technologies such as mobile, social media, point-of-sale transactions, beaconing, and web-based media.

Share on Social Networks: